The store at 1515 W. State St. near downtown was planned to be sold to CVS Pharmacy as part of Rite Aid’s bankruptcy ...

CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory ...

A federal judge tripled damages against the pharmacy benefits manager after finding it encouraged inflated Medicare drug ...

CVS rejected coverage of Gilead's new HIV prevention drug Yeztugo, citing regulatory and financial factors, while facing nearly $290 million in Medicare overcharge penalties.

A federal judge has ordered CVS Caremark to pay nearly $290 million in damages after determining the pharmacy benefit manager overbilled Medicare for prescription drugs, according to court documents ...

Regulators have also imposed $160,000 in fines on Cigna's Express Scripts unit; $66,000 in fines on Rightway PBM Services; ...

Notably, the case came from a whistleblower lawsuit filed by Sarah Behnke, a former Medicare Part D actuary at Aetna, who ...

It was the "physical embodiment of the narrative that has taken over, attacking science, and attacking our federal workers," ...

UofL Health is putting a pause on plans to bring maternity services to south Louisville.

CVS Health posted strong second-quarter results and raised its full-year guidance following strong performances in its Aetna and pharmacy segments, but its healthcare delivery segment remains ...

Shares of CVS Health jumped Thursday after the health care giant posted better-than-expected second-quarter results and lifted its full-year adjusted profit forecast.

While competitors continue to struggle with healthcare costs, Aetna and CVS are celebrating an 8.4% increase in second-quarter revenues.